Adrienne G. Culver

Associate

Atlanta + 1.404.581.8246

Contact

Partager

Adrienne Culver practices corporate law, with a focus on public and private M&A. She advises public and private companies, as well as private equity firms, in domestic and cross-border mergers, acquisitions, divestitures, and other complex and strategic transactions. She has experience advising clients across various industries, including retail, health care, biotechnology, and manufacturing.

Adrienne maintains an active pro bono practice and is a member of the board of directors of AWARE Wildlife Center.

Expérience

  • Strata Decision Technology acquires c.myersJones Day advised Roper Technologies, Inc. and its subsidiary Strata Decision Technology, a leading provider of enterprise performance management solutions for financial institutions, in its acquisition of c. myers, a trusted advisory firm that has worked with more than 600 financial institutions over the course of its 30-plus-year history.
  • Kroger announces agreement to acquire Giant Eagle for $1.65 billionJones Day is advising The Kroger Co. in the $1.65 billion acquisition of Giant Eagle, Inc., a leading family-owned food and pharmacy retailer with approximately $9 billion in annual sales and 197 supermarkets and 11 standalone pharmacies across northern Ohio, western Pennsylvania, West Virginia, Maryland and Indiana.
  • FN Browning acquires Accuracy InternationalJones Day is advising FN Browning Group in the acquisition of Accuracy International, a global specialist in precision bolt-action rifle systems.
  • Enhabit acquired by Kinderhook IndustriesJones Day advised Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, in the acquisition of Enhabit by Kinderhook Industries, LLC, a leading middle market private equity fund, in an all-cash transaction for a total enterprise value of approximately $1.1 billion.
  • Axion Biosystems acquires CytoTronics, Inc.Jones Day advised Axion Biosystems, Inc, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging systems, in the acquisition of the intellectual property and assets of CytoTronics, Inc., including high-density (HD) electrode array technology to provide researchers with the most advanced tools for disease research and drug discovery.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.